This inventor holds 1 USPTO granted patent. Top assignees: Monopar Therapeutics, Inc., Northstar Medical Technologies, LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 11 Years Active: 2026
Title: Andrew Mazar and His Radiopharmaceutical Patent.
Introduction
Andrew Mazar is an inventor associated with Lake Forest, Illinois. His work includes a patent for a radiopharmaceutical approach targeting the urokinase plasminogen activator receptor.
Latest Patents
Mazar is credited with 1 patent: “Urokinase Plasminogen Activator Receptor-Targeted Radiopharmaceutical.” The invention focuses on targeting the urokinase plasminogen activator receptor, a subject of interest in biomedical research.
Career Highlights
Mazar has been associated with NorthStar Medical Technologies, LLC, and Monopar Therapeutics, Inc. These companies work in areas related to medical technology and therapeutics.
Collaborations
His listed coworkers include James T. Harvey and R. Keith Frank.
Conclusion
Andrew Mazar’s patent reflects his involvement in radiopharmaceutical innovation, alongside professional associations with NorthStar Medical Technologies and Monopar Therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile